Edwards Lifesciences (EW) Assets Average (2010 - 2026)

Edwards Lifesciences has reported Assets Average for 17 years, with the latest figure at $13.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 3.61% year-over-year to $13.5 billion; the trailing twelve-month figure through Mar 2026 stood at $13.5 billion (up 3.61% YoY), and the FY2025 full-year result was $13.4 billion, up 19.33% from the prior year.
• Assets Average for Q1 2026 stood at $13.5 billion, roughly flat from $13.5 billion in the prior quarter.
• The five-year high for Assets Average was $13.5 billion in Q1 2026, with the low at $8.4 billion in Q2 2022.
• Average Assets Average over 5 years is $10.6 billion, with a median of $9.5 billion recorded in 2024.
• Year-over-year, Assets Average rose 0.13% in 2023 and surged 38.93% in 2024.
• Tracing EW's Assets Average over 5 years: stood at $8.5 billion in 2022, then climbed by 10.65% to $9.4 billion in 2023, then surged by 38.93% to $13.0 billion in 2024, then climbed by 3.62% to $13.5 billion in 2025, then climbed by 0.18% to $13.5 billion in 2026.
• The last three Assets Average figures came in at $13.5 billion (Q1 2026), $13.5 billion (Q4 2025), and $13.4 billion (Q3 2025), per Business Quant data.

Peer Comparison